Socioeconomic evaluation of clinical practice in cardiology;Evaluación socioeconómica de la práctica clínica cardiológica

Revista Espanola de Cardiologia

Volumn 50, Issue 6, 1997, Pages 428-443

  Lázaro y De Mercado, Pablo ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Costs; Economic appraisal; Efficiency; Outcomes; QALYs

Indexed keywords

ARTICLE; CARDIOLOGY; ECONOMICS; PROFESSIONAL PRACTICE; SPAIN;

CARDIOLOGY; PROFESSIONAL PRACTICE; SPAIN;

EID: 0031154725     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0300-8932(97)73245-7     Document Type: Review

References (62)

1. Lázaro P, Pozo F, Ricoy JR. Una estrategia de investigación en el sistema nacional de salud: II. Investigación en servicios de salud. Med Clin (Barc) 1995; 104: 67-76.
2. Drummond M, Stoddart G, Labelle R, Cushman R. Health economics: an introduction for clinicians. Ann Intern Med 1987; 107: 88-92.
3. OECD. OECD HEALTH DATA. A software package for the international comparison of health care systems. Version 1.5. París, Francia, 1993.
4. Culyer AJ. The morality of efficiency in health care - some uncomfortable implications. Health Economics 1992; 1: 7-18.
5. Hutton J. Economic evaluation of health care: a half-way technology. Health Economics 1994; 3: 1-4.
6. Adams ME, McCall NT, Gray DT, Orza MJ, Chalmers TC. Economic analysis in randomized clinical trials. Med Care 1992; 30: 231-243
7. Udvarhelyi IS, Colditz GA, Rai A, Epstein AM. Cost-effectiveness and cost-benefit analysis in the medical literature: are the methods being used correctly? Ann Intern Med 1992; 116: 238-244.
8. Lázaro P. ¿Qué sabemos de la evaluación socioeconómica de la práctica clínica? Algunas reflexiones a partir de un análisis de coste-efectividad de las exploraciones pronósticas en el infarto agudo de miocardio no complicado. Rev Esp Cardiol 1993; 46: 483-485.
9. Luce BR, Elixhauser A. Standards for the socioeconomic evaluation of health care services. En: Culyer AJ, editor. Berlín Springer-Verlag, 1990.
10. Lázaro P. Evaluación de Tecnología Médica. Papeles de Gestion Sanitaria. Monografía II. Valencia: M/C/Q Ediciones, 1994.
11. Pozo F, Ricoy JR, Lázaro P. Una estrategia de investigación en el sistema nacional de salud: I. La Epidemiología clinica. Med Clin (Barc) 1994; 102: 664-669.
12. Pozo Rodríguez F. La eficacia de las pruebas diagnósticas (I) Med Clin (Barc) 1988; 90: 779-785.
13. Pozo Rodríguez F. La eficacia de las pruebas diagnósticas (II). Med Clin (Barc) 1988; 91: 177-183.
14. Hilbome LH, Leape LL, Kahan JP, Park RE, Kamberg CJ, Brook RH. Percutaneous transluminal coronary angioplasty. A literature review and ratings of appropriateness and necessity. RAND JRA-01 1991.
15. Dorros G, Lewin R, Janke L. Multiple lesions transluminal coronary angioplasty in single and multivessel coronary artery disease: acute outcome and long-term effect. J Am Coll Cardiol 1987; 10: 1.007-1.013.
16. Mainar Tello V, Gómez Recio M, Martínez Elbal, Pan M. Registro Nacional de Actividad de Hemodinámica y Cardiologia Intervencionista en los an̄os 1990 y 1991. Rev Esp Cardiol 1992; 45: 622-626.
17. NHLBI Conference. Evaluation of Emerging Technologies for Coronary Revascularization. Circulation 1992; 85: 357-361.
18. Topol EJ, Leya F, Pinkerton CA et al. A comparison of directional atherectomy with coronary angioplasty in patientes with coronary artery disease. N Engl J Med 1993; 329: 221-227.
19. Kind P. The design and construction of quality of life measures. Discussion paper 43. Centre for Health Economics. University of York, Reino Unido, 1988.
20. The EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy 1990; 16: 199-208.
21. RAND Health Sciences Program. RAND 36-item health survey 1.0. Santa Monica: RAND, 1992.
22. Mehrez A, Gafni A. Quality-adjusted life years, utility theory and health-years equivalents. Medical Decision Making 1989; 9: 142-149.
23. Fitzpatrick R, Fletcher A, Gore S, Jones D, Spiegelhalter D, Cox D. Quality of life measures in health care. I: Applications and issues in assessment BMJ 1992; 305: 1.047-1.057.
24. Robinson R. Economic evaluation and health care. Cost-utility analysis. BMJ 1993; 307: 859-862.
25. Drummond MF, Heyse J, Cook J, McGuire A. Selection of end points in economic evaluations of coronary-heart disease interventions. Med Decis Making 1993; 13: 184-190.
26. Williams A. Economics of coronary artery bypass grafting. BMJ 1985; 291: 326-329.
27. Mehrez A, Gafni A. Healthy-years equivalents versus Quality-adjusted life years: in pursuit of progress. Med Decis Making 1993; 13: 287-292.
28. Robinson R. Economic evaluation and health care. Cost-benefit analysis. BMJ 1993; 307: 924-926.
29. Oriol A, Augé JM, Crexells C. Aspectos socioeconómicos. Comparación con la cirugía de bypass aortocoronario. Jano 1987; 33: 1.225-1.227.
30. Bresco S, Oriol A, García J, Augé JM, Crexells C. Coste de la ACTP en un hospital terciario de nuestro medio. Rev Esp Cardiol 1985; 38 (Supl 1): 79-82.
31. The expanding scope of coronary angioplasty. Lancet 1985; 1: 1.307-1.308.
32. Reeder GS. Angioplasty and the cost of myocardial revascularization: has its promise been fulfilled? Int J Cardiol 1987; 15: 287-292.
33. Reeder GS, Krishan I, Nobrega FT, Naessens J, Kelly M, Christianson JB et al. Is percutaneous angioplasty less expensive than bypass surgery? N Engl J Med 1984; 311: 1.157-1.162.
34. Berreklouw E, Hoogsteen J, Van Wandelen R, Verkroost M, Schonberger J, Bavink H et al. Bilateral mammary artery surgery or percutaneous transluminal angioplasty for multivessel coronary artery disease? An analysis of effects and costs. Eur Heart J 1989; 10 (Supl H): 61-70.
35. Kouchoukos NT. Percutaneous transluminal coronary angioplasty: a surgeon's view. Circulation 1985; 72: 1.144-1.147.
36. Cooper IC, Signy M, Webb-Peploe MM, Coltart DJ. Coronary angioplasty. Postgrad Med J 1987; 63: 327-335.
37. Jang GC, Block PC, Cowley MJ et al. Relative costs of coronary angioplasty and bypass surgery in a one-vessel disease model. Am J Cardiol 1984; 53: 52C-55C.
38. Pennsylvania Health Care Cost Containment Council. A Consumer Guide to Coronary Artery Bypass Graft Surgery. Harrisburg, PA, 1993.
39. Taylor GJ, Mikell FL, Moses HW et al. Determinants of hospital charges for coronary artery bypass surgery: the economic consequences of postoperative complications. Am J Cardiol 1990; 65: 309-313.
40. Australian Institute of Health and Welfare. Excimer lasers in coronary angioplasty. Health Care Technoloy News 1992; 6: 5-6.
41. Drummond M. Assessing efficiency in the new National Health Service. Discussion paper 75. Centre for Health Economics. University of York, York. Reino Unido, 1990.
42. Lázaro P, Azcona B. Clinical practice. ethics and economics: the physician at the crossroads. Health Policy 1996; 37: 185-198.
43. Williams A. Economia sanitaria: ¿el fin de la libertad clínica? BMJ (ed. esp.) 1989; 4: 66-71.
44. Mooney GH. The inefficiency of medical ethics. En: Economics, medicine and health care. Londres: Harvester Wheatsheaf, 1989; 88-106.
45. Smith A, chairman. The ethics of resource allocation. J Epidemiol Commun Health 1990; 44: 187-190.
46. a ed.). Filadelfia: Saunders Company, 1988; 1.680-1.692.
47. Lázaro P, Fitch K. From universalism to selectivity, is «appropriateness» the answer? Health Policy 1996; 36: 261-272.
48. Brook RH. Health services research: is it good for you and me? Acad Med 1989; 64: 124-130.
49. Bernstein SJ, Kosecoff J, Gray D, Hampton JR, Brook RH. The appropriateness of the use of cardiovascular procedures. British versus U.S. perspectives. Intern J Technol Assess Health Care 1993; 9: 3-10.
50. Brook RH. Health, health insurance, and the uninsured. JAMA 1991; 265: 2.998-3.002.
51. Hilbome LH, Leape LL, Bernstein SJ, Park RE, Fiske ME, Kamberg CJ et al. The appropriateness of use of percutaneous transluminal coronary angioplasty in New York State. JAMA 1993; 269: 761-765.
52. Bernstein SJ, Hilborne LH, Leape LL, Fiske ME, Park RE, Kamberg CJ et al. The appropriateness of use of coronary angiography in New York State. JAMA 1993; 269: 766-769.
53. Winslow CR, Kosecoff J, Chassin MR, Kanouse DE, Brook RH. The appropriateness of performing coronary artery bypass surgery. JAMA 1988; 260: 505-509.
54. Gray D, Hampton JR, Bernstein SJ, Kosecoff J, Brook RH. Audit of coronary angiography and bypass surgery. Lancet 1990; 335: 1.317-1.320.
55. Woolhandler S, Himmelstein DU. The deteriorating administrative efficiency of the U.S. health care system. N Engl J Med 1991; 324: 1.253-1.258.
56. Woolhandler S, Himmelstein DU, Lewontin JP. Administrative costs in U.S. hospitals. N Engl J Med 1993; 329: 400-403.
57. Läzaro P. Angioplastia coronaria y cirugía coronaria: algunas consideraciones socioeconómicas. Rev Esp Cardiol 1993; 46 (Supl 3): 1-14.
58. Weinstein MC, Stason WB. Cost-effectiveness of coronary artery bypass surgery. Circulation 1982; 66 (Supl 3): 56-66.
59. Drummond MF. Principles of economic appraisal in health care. Oxford: Oxford Medical Publications, 1989.
60. Lázaro P, Fitch K. Economic incentives and the distribution of extracorporeal shock wave lithotripters and linear accelerators in Spain. Int J Tech Ass Health Care 1996; 12: 735-744.
61. Department of Clinical Epidemiology and Biostatistics, McMaster Health Sciences Centre. How to read clinical journals: VII: to understand an economic evaluation (Part A). Can Med Assoc J 1984; 130: 1.428-1.434.
62. Department of Clinical Epidemiology and Biostatistics, McMaster Health Sciences Centre. How to read clinical journals: VII: to understand an economic evaluation (Part B). Can Med Assoc J 1984; 130: 1.542-1.549.